1379 related articles for article (PubMed ID: 22722201)
21. Mutational landscape and significance across 12 major cancer types.
Kandoth C; McLellan MD; Vandin F; Ye K; Niu B; Lu C; Xie M; Zhang Q; McMichael JF; Wyczalkowski MA; Leiserson MDM; Miller CA; Welch JS; Walter MJ; Wendl MC; Ley TJ; Wilson RK; Raphael BJ; Ding L
Nature; 2013 Oct; 502(7471):333-339. PubMed ID: 24132290
[TBL] [Abstract][Full Text] [Related]
22. A compendium of mutational cancer driver genes.
Martínez-Jiménez F; Muiños F; Sentís I; Deu-Pons J; Reyes-Salazar I; Arnedo-Pac C; Mularoni L; Pich O; Bonet J; Kranas H; Gonzalez-Perez A; Lopez-Bigas N
Nat Rev Cancer; 2020 Oct; 20(10):555-572. PubMed ID: 32778778
[TBL] [Abstract][Full Text] [Related]
23. Chromatin accessibility of primary human cancers ties regional mutational processes and signatures with tissues of origin.
Ocsenas O; Reimand J
PLoS Comput Biol; 2022 Aug; 18(8):e1010393. PubMed ID: 35947558
[TBL] [Abstract][Full Text] [Related]
24. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
25. Landscape and function of multiple mutations within individual oncogenes.
Saito Y; Koya J; Araki M; Kogure Y; Shingaki S; Tabata M; McClure MB; Yoshifuji K; Matsumoto S; Isaka Y; Tanaka H; Kanai T; Miyano S; Shiraishi Y; Okuno Y; Kataoka K
Nature; 2020 Jun; 582(7810):95-99. PubMed ID: 32494066
[TBL] [Abstract][Full Text] [Related]
26. The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study.
Guerini-Rocco E; Hodi Z; Piscuoglio S; Ng CK; Rakha EA; Schultheis AM; Marchiò C; da Cruz Paula A; De Filippo MR; Martelotto LG; De Mattos-Arruda L; Edelweiss M; Jungbluth AA; Fusco N; Norton L; Weigelt B; Ellis IO; Reis-Filho JS
J Pathol; 2015 Oct; 237(2):166-78. PubMed ID: 26011570
[TBL] [Abstract][Full Text] [Related]
27. The genetic landscape of breast carcinomas with neuroendocrine differentiation.
Marchiò C; Geyer FC; Ng CK; Piscuoglio S; De Filippo MR; Cupo M; Schultheis AM; Lim RS; Burke KA; Guerini-Rocco E; Papotti M; Norton L; Sapino A; Weigelt B; Reis-Filho JS
J Pathol; 2017 Feb; 241(3):405-419. PubMed ID: 27925203
[TBL] [Abstract][Full Text] [Related]
28. MUFFINN: cancer gene discovery via network analysis of somatic mutation data.
Cho A; Shim JE; Kim E; Supek F; Lehner B; Lee I
Genome Biol; 2016 Jun; 17(1):129. PubMed ID: 27333808
[TBL] [Abstract][Full Text] [Related]
29. Genomic characterization of metastatic breast cancers.
Bertucci F; Ng CKY; Patsouris A; Droin N; Piscuoglio S; Carbuccia N; Soria JC; Dien AT; Adnani Y; Kamal M; Garnier S; Meurice G; Jimenez M; Dogan S; Verret B; Chaffanet M; Bachelot T; Campone M; Lefeuvre C; Bonnefoi H; Dalenc F; Jacquet A; De Filippo MR; Babbar N; Birnbaum D; Filleron T; Le Tourneau C; André F
Nature; 2019 May; 569(7757):560-564. PubMed ID: 31118521
[TBL] [Abstract][Full Text] [Related]
30. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution.
Shah SP; Morin RD; Khattra J; Prentice L; Pugh T; Burleigh A; Delaney A; Gelmon K; Guliany R; Senz J; Steidl C; Holt RA; Jones S; Sun M; Leung G; Moore R; Severson T; Taylor GA; Teschendorff AE; Tse K; Turashvili G; Varhol R; Warren RL; Watson P; Zhao Y; Caldas C; Huntsman D; Hirst M; Marra MA; Aparicio S
Nature; 2009 Oct; 461(7265):809-13. PubMed ID: 19812674
[TBL] [Abstract][Full Text] [Related]
31. The clonal and mutational evolution spectrum of primary triple-negative breast cancers.
Shah SP; Roth A; Goya R; Oloumi A; Ha G; Zhao Y; Turashvili G; Ding J; Tse K; Haffari G; Bashashati A; Prentice LM; Khattra J; Burleigh A; Yap D; Bernard V; McPherson A; Shumansky K; Crisan A; Giuliany R; Heravi-Moussavi A; Rosner J; Lai D; Birol I; Varhol R; Tam A; Dhalla N; Zeng T; Ma K; Chan SK; Griffith M; Moradian A; Cheng SW; Morin GB; Watson P; Gelmon K; Chia S; Chin SF; Curtis C; Rueda OM; Pharoah PD; Damaraju S; Mackey J; Hoon K; Harkins T; Tadigotla V; Sigaroudinia M; Gascard P; Tlsty T; Costello JF; Meyer IM; Eaves CJ; Wasserman WW; Jones S; Huntsman D; Hirst M; Caldas C; Marra MA; Aparicio S
Nature; 2012 Apr; 486(7403):395-9. PubMed ID: 22495314
[TBL] [Abstract][Full Text] [Related]
32. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.
Silva GO; He X; Parker JS; Gatza ML; Carey LA; Hou JP; Moulder SL; Marcom PK; Ma J; Rosen JM; Perou CM
Breast Cancer Res Treat; 2015 Jul; 152(2):347-56. PubMed ID: 26109346
[TBL] [Abstract][Full Text] [Related]
33. Network-based approaches elucidate differences within APOBEC and clock-like signatures in breast cancer.
Kim YA; Wojtowicz D; Sarto Basso R; Sason I; Robinson W; Hochbaum DS; Leiserson MDM; Sharan R; Vadin F; Przytycka TM
Genome Med; 2020 May; 12(1):52. PubMed ID: 32471470
[TBL] [Abstract][Full Text] [Related]
34. Identification of collaborative driver pathways in breast cancer.
Liu Y; Hu Z
BMC Genomics; 2014 Jul; 15(1):605. PubMed ID: 25034939
[TBL] [Abstract][Full Text] [Related]
35. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
36. Revealing clonality and subclonality of driver genes for clinical survival benefits in breast cancer.
Lan Y; Zhao E; Luo S; Xiao Y; Li X; Cheng S
Breast Cancer Res Treat; 2019 May; 175(1):91-104. PubMed ID: 30739230
[TBL] [Abstract][Full Text] [Related]
37. Commonalities and differences in the mutational signature and somatic driver mutation landscape across solid and hollow viscus organs.
Ng AS; Chan DKH
Oncogene; 2023 Sep; 42(37):2713-2724. PubMed ID: 37573406
[TBL] [Abstract][Full Text] [Related]
38. The breast cancer somatic 'muta-ome': tackling the complexity.
Teschendorff AE; Caldas C
Breast Cancer Res; 2009; 11(2):301. PubMed ID: 19344493
[TBL] [Abstract][Full Text] [Related]
39. Identification of coding and non-coding mutational hotspots in cancer genomes.
Piraino SW; Furney SJ
BMC Genomics; 2017 Jan; 18(1):17. PubMed ID: 28056774
[TBL] [Abstract][Full Text] [Related]
40. Transposon insertional mutagenesis in mice identifies human breast cancer susceptibility genes and signatures for stratification.
Chen L; Jenjaroenpun P; Pillai AM; Ivshina AV; Ow GS; Efthimios M; Zhiqun T; Tan TZ; Lee SC; Rogers K; Ward JM; Mori S; Adams DJ; Jenkins NA; Copeland NG; Ban KH; Kuznetsov VA; Thiery JP
Proc Natl Acad Sci U S A; 2017 Mar; 114(11):E2215-E2224. PubMed ID: 28251929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
